National Healthcare earnings release, May 8, 2026

National Healthcare Corp (NHC) · Form 8-K, Item 2.02 · Filed · SEC filing

For release: May 8, 2026

Contact: Brian F. Kidd, SVP/CFO

Phone: (615) 890-2020

NHC Reports First Quarter 2026 Earnings

MURFREESBORO, Tenn. --

National HealthCare Corporation

(NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended March 31, 2026 totaled $381,821,000 compared to $373,697,000 for the quarter ended March 31, 2025, an increase of 2.2%.

For the quarter ended March 31, 2026, the reported GAAP net income attributable to NHC was $35,857,000 compared to $32,205,000 for the same period in 2025. Excluding the unrealized gains in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended March 31, 2026 was $30,089,000 compared to $24,838,000 for the same period in 2025, an increase of 21.1%

(*). The GAAP diluted earnings per share were $2.27 and $2.07 for the quarters ending March 31, 2026 and 2025, respectively. Adjusted diluted earnings per share were $1.91 and $1.59 for the quarters ending March 31, 2026 and 2025, respectively

(*).

(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.

About NHC

As of May 1, 2026, NHC affiliates operate for themselves and third parties 80 skilled nursing facilities with 10,323 beds. NHC affiliates also operate 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Financial statements

Income Statement

Three Months Ended — (in thousands, except share and per share amounts)

Three Months Ended – March 31 – 2026 – (unaudited)Three Months Ended – March 31 – 2025 – (unaudited)
Revenues:Net patient revenues369,805361,607
Revenues:Other revenues12,01612,090
Revenues:Net operating revenues381,821373,697
Costs and expenses:Salaries, wages and benefits235,074228,130
Costs and expenses:Other operating91,23792,457
Costs and expenses:Facility rent11,64311,365
Costs and expenses:Depreciation and amortization11,61410,978
Costs and expenses:Total costs and expenses349,568342,930
Costs and expenses:Income from operations32,25330,767
Costs and expenses:Non-operating income3,7574,079
Costs and expenses:Interest expense-269-2,106
Costs and expenses:Unrealized gains on marketable equity securities9,07410,982
Costs and expenses:Income before income taxes44,81543,722
Costs and expenses:Income tax provision-8,712-11,432
Costs and expenses:Net income36,10332,290
Costs and expenses:Net income attributable to noncontrolling interest-246-85
Costs and expenses:Net income attributable to National HealthCare Corporation35,85732,205
Net income per common shareBasic2.312.09
Net income per common shareDiluted2.272.07
Weighted average common shares outstandingBasic15,541,63415,438,306
Weighted average common shares outstandingDiluted15,770,50715,575,752
Weighted average common shares outstandingDividends declared per common share0.640.61

Income Statement

Three Months Ended — : (in thousands)

Three Months Ended – March 31 – 2026 – (unaudited)Three Months Ended – March 31 – 2025 – (unaudited)
Net income attributable to National Healthcare Corporation35,85732,205
Non-GAAP adjustmentsUnrealized gains on marketable equity securities-9,074-10,982
Non-GAAP adjustmentsStock-based compensation expense1,2801,027
Non-GAAP adjustmentsIncome tax provision on non-GAAP adjustments2,0262,588
Non-GAAP adjustmentsNon-GAAP Net income30,08924,838
Non-GAAP adjustmentsGAAP diluted earnings per share2.272.07
Non-GAAP adjustmentsUnrealized gains on marketable equity securities-0.57-0.71
Non-GAAP adjustmentsStock-based compensation expense0.080.06
Non-GAAP adjustmentsIncome tax provision on non-GAAP adjustments0.130.17
Non-GAAP adjustmentsNon-GAAP diluted earnings per share1.911.59

Balance Sheet

Balance Sheet Data — (in thousands, except share and per share amounts)

March 31 – 2026December 31 – 2025
Cash, cash equivalents and marketable securities258,352255,801
Restricted cash, cash equivalents and marketable securities160,258159,848
Current assets465,576461,820
Property and equipment, net671,823673,797
Total assets1,524,0941,526,419
Current liabilities250,825246,132
Current and long-term debt40,000
NHC stockholders' equity1,090,9491,068,772
Full release

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.

-more-

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

-more-

Selected Operating Statistics

The tables below provide reconciliations of GAAP to non-GAAP items

(in thousands, except per share amounts)

:

###

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · National Healthcare earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.